ELDN — ELEDON PHARMACEUTICALS INC

Ownership history in 22NW, LP  ·  4 quarters on record

This page tracks every 13F SEC filing in which 22NW, LP reported a position in ELEDON PHARMACEUTICALS INC (ELDN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.45% (2025 Q1)
Avg. % of fund
0.93%
First filed
2025 Q1
Last filed
2025 Q4
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 636,364 — 0% 0.40% $961K $1.51
2025 Q3 UNCHANGED 636,364 — 0% 0.78% $1.6M $2.59
2025 Q2 UNCHANGED 636,364 — 0% 1.09% $1.7M $2.71
2025 Q1 INITIATED 636,364 — — 1.45% $2.2M $3.39
% of Fund (quarterly)    ELDN price (monthly, adj. close)

Other funds also holding ELDN

As of 2025 Q4 — sorted by position size

Stonepine Capital Management, LLC 3Y 7Y 0.98% CM Management, LLC 3Y 0.83% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 0.62% Catalio Capital Management, LP 0.34% BVF INC/IL 3Y 7Y 0.32% Blue Owl Capital Holdings LP 3Y 0.22% ADAR1 Capital Management, LLC 0.2% KINGDON CAPITAL MANAGEMENT, L.L.C. 3Y 7Y 0.19% AWM Investment Company, Inc. 3Y 7Y 0.16% Zimmer Partners, LP 3Y 7Y 0.09%
← Back to 22NW, LP Holdings